Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome.

Clinical trial NCT07471490 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07471490
Sponsor: DiaSorin Inc.
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

IBD (Inflammatory Bowel Disease)IBS (Irritable Bowel Syndrome)Gastrointestinal Symptoms

Start date: 2025-05-07
Primary completion: 2026-08-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.